|
|
||||||||
Clinical Research Center, College of Medicine, Inha University, 7-206, 3-Ga, Shinheung-Dong, Chung-Gu, Inchon 400-711, Korea
Correspondence
Sun Song
sunuksong{at}inha.ac.kr
Efficient gene delivery of a baculovirus-derived vector (BV-p53-lacZ) to a human osteogenic sarcoma cell line, Saos-2, was serendipitously found while evaluating the vector for gene delivery to human p53-null tumour cells in a previous study. Therefore, we investigated other human, rat and mouse osteogenic sarcoma and other types of tumour cell lines for transduction efficiency via baculovirus vectors containing a lacZ reporter gene under the control of either a cytomegalovirus or Rous sarcoma virus promoter. The expression of
-galactosidase protein, assessed by X-Gal staining and
-galactosidase ELISA, demonstrated an extremely high level of transduction efficiency in some osteogenic sarcoma cell lines, such as U-2OS, Saos-2 and Saos-LM2. These human osteogenic sarcoma cell lines showed levels of
-galactosidase expression 540 times greater than HepG2 cells, which were previously thought to be the mammalian cells most susceptible to baculovirus-mediated gene delivery. The level of acetylated histone proteins in these tumour lines did not correlate well with the high level of reporter gene expression. These results strongly suggest that some osteogenic sarcoma cells are highly susceptible to baculovirus-mediated gene delivery and that a baculovirus-derived vector is an efficient gene delivery vehicle into human osteogenic sarcoma cells.
This article has been cited by other articles:
![]() |
H. Matilainen, J. Rinne, L. Gilbert, V. Marjomaki, H. Reunanen, and C. Oker-Blom Baculovirus Entry into Human Hepatoma Cells J. Virol., December 15, 2005; 79(24): 15452 - 15459. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Katso, J. H. Parham, M. Caivano, W. C. Clay, J. P. Condreay, D. W. Gray, K. M. Lindley, S. J. Mason, J. Rieger, N. C. Wakes, et al. Evaluation of Cell-Based Assays for Steroid Nuclear Receptors Delivered by Recombinant Baculoviruses J Biomol Screen, October 1, 2005; 10(7): 715 - 724. [Abstract] [PDF] |
||||
![]() |
M. Salminen, K. J. Airenne, R. Rinnankoski, J. Reimari, O. Valilehto, J. Rinne, S. Suikkanen, S. Kukkonen, S. Yla-Herttuala, M. S. Kulomaa, et al. Improvement in Nuclear Entry and Transgene Expression of Baculoviruses by Disintegration of Microtubules in Human Hepatocytes J. Virol., March 1, 2005; 79(5): 2720 - 2728. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. P. Oomens and G. W. Wertz The Baculovirus GP64 Protein Mediates Highly Stable Infectivity of a Human Respiratory Syncytial Virus Lacking Its Homologous Transmembrane Glycoproteins J. Virol., January 1, 2004; 78(1): 124 - 135. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tani, C. K. Limn, C. C. Yap, M. Onishi, M. Nozaki, Y. Nishimune, N. Okahashi, Y. Kitagawa, R. Watanabe, R. Mochizuki, et al. In Vitro and In Vivo Gene Delivery by Recombinant Baculoviruses J. Virol., September 15, 2003; 77(18): 9799 - 9808. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |